Cedrol, a Ginger-derived sesquiterpineol, suppresses estrogen-deficient osteoporosis by intervening NFATc1 and reactive oxygen species.

MLA

Xu, Cong, et al. “Cedrol, a Ginger-Derived Sesquiterpineol, Suppresses Estrogen-Deficient Osteoporosis by Intervening NFATc1 and Reactive Oxygen Species.” International Immunopharmacology, vol. 117, Apr. 2023, p. 109893. EBSCOhost, https://doi.org/10.1016/j.intimp.2023.109893.

APA

Xu, C., Jin, S.-Q., Jin, C., Dai, Z.-H., Wu, Y.-H., He, G.-L., Ma, H.-W., Xu, C.-Y., & Fang, W.-L. (2023). Cedrol, a Ginger-derived sesquiterpineol, suppresses estrogen-deficient osteoporosis by intervening NFATc1 and reactive oxygen species. International Immunopharmacology, 117, 109893. https://doi.org/10.1016/j.intimp.2023.109893

Chicago

Xu, Cong, Shu-Qing Jin, Chen Jin, Zi-Han Dai, Yu-Hao Wu, Gao-Lu He, Hai-Wei Ma, Chao-Yi Xu, and Wen-Lai Fang. 2023. “Cedrol, a Ginger-Derived Sesquiterpineol, Suppresses Estrogen-Deficient Osteoporosis by Intervening NFATc1 and Reactive Oxygen Species.” International Immunopharmacology 117 (April): 109893. doi:10.1016/j.intimp.2023.109893.